As of Feb 12
| +0.44 / +1.00%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 129.00, with a high estimate of 150.00 and a low estimate of 23.39. The median estimate represents a +188.98% increase from the last price of 44.64.
The current consensus among 7 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.